Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report

Background. While the clinical benefits of terlipressin (TP) have been reported in adults and children with refractory hypotension, data in neonates are limited. Case. Herein, we report a case of off-label rescue TP therapy in a neonate with septic shock and persistent hypotension. The patient’s blood pressure was normalized, and tissue perfusion improved without serious adverse reactions. However, genetic testing revealed mitochondrial gene defects in the patient, and the parents subsequently elected to stop treatment after 25 doses of TP (20 μg/kg/min every 4 h for 100 h). Conclusion. While TP treatment appeared to help control hypotension and may prolong the survival time, there are no conclusive data regarding the safety and efficacy of TP in neonates.

PDF

___

1. Bidegain M, Greenberg R, Simmons C, Dang C, Cotten CM, Smith PB. Vasopressin for refractory hypotension in extremely low birth weight infants J Pediatr 2010; 157: 502-504.

2. Fanaroff AA, Fanaroff JM. Short-and long-term consequences of hypotension in ELBW infants. Semin Perinatol 2006; 30: 151-155.

3. Matok I, Vard A, Efrati O, et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children.Shock 2005; 23: 305-310.

4. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359: 1209-1210.

5. Rodriguez-Nunez A, Oulego-Erroz I, Gil-Anton J, et al; RETSPED-II Working Group of the Spanish Society of Pediatric Intensive Care. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann Pharmacother 2010; 44: 1545-1553.

6. Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: pharmacology and its clinical relevance Anaesthesia 2004; 59: 993-1001.

7. Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 2008; 34: 511-517.

8. Shivanna B, Rios D, Rossano J, Fernandes CJ, Pammi M. Vasopressin and its analogues for the treatment of refractory hypotension in neonates. Cochrane Database Syst Rev 2013: CD009171.

9. Matok I, Leibovitch L, Vardi A, et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5: 116-118.

10. Filippi L, Gozzini E, Daniotti M, Pagliai F, Catarzi S, Fiorini P. Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med 2011; 12: e237-e241.

11. Radicioni M, Troiani S, Camerini PG. Effects of terlipressin on pulmonary artery pressure in a septic cooled infant: an echocardiographic assessment. J Perinatol 2012; 32: 893-895.

12. Stathopoulos L, Nicaise C, Michel F, et al. Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia. J Pediatr Surg 2011; 46: e19-e21.

13. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, González-Alonso N, MartinónSánchez JM. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004; 30: 477-480.

14. Zeballos G, Lopez-Herce J, Fernandez C, Brandstrup KB, Rodríguez-Núñez A. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation 2006; 68: 151-153.

15. Scharte M, Meyer J, Van Aken H, et al. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29: 1756-1760.

16. Krag A, Hobolth L, Moller S, Bendtsen F. Hyponatraemia during terlipressin therapy. Gut 2010; 59: 417-418.